Document is current
Any future updates will be listed below
-
Authors
Nguyen, Anh Phuong
Yamagata, Kaoru
Iwata, Shigeru
Trimova, Gulzhan
Zhang, Tong
Shan, Yu
Nguyen, Mai-Phuong
Sonomoto, Koshiro
Nakayamada, Shingo
Kato, Shigeaki
Tanaka, Yoshiya https://orcid.org/0000-0002-0807-7139
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare
- License Information
-
More Information
Article History
Received: 16 June 2022
Accepted: 24 August 2022
First Online: 16 September 2022
Declarations
:
: Y. Tanaka has received consulting fees, speaking fees, and/or honoraria from Daiichi-Sankyo, Astellas, Pfizer, Mitsubishi-Tanabe, Bristol-Myers, Chugai, YL Biologics, Eli Lilly, Sanofi, Janssen, and UCB and has received research grants from Mitsubishi-Tanabe, Takeda, Bristol-Myers, Chugai, Astellas, Abbvie, MSD, Daiichi-Sankyo, Pfizer, Kyowa-Kirin, Eisai, and Ono. S. Nakayamada has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers, AstraZeneca, Pfizer, GlaxoSmithKline, Astellas, Asahi-kasei, Sanofi, Abbvie, Eisai, Chugai, Gilead, Boehringer Ingelheim and has received research grants from Mitsubishi-Tanabe.
